Sareum Holdings Plc - Company Profile
Powered by 
All the data and insights you need on Sareum Holdings Plc in one report.
$295
- Save hours of research time and resources with
our up-to-date Sareum Holdings Plc Strategy Report
- Understand Sareum Holdings Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Sareum Holdings Plc Clinical Trials
Determine Sareum Holdings Plc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Sareum Holdings Plc Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| Phase I Study of SDC-1801 in Severe-phase COVID-19 Subjects | GDCT0408411 | SDC-1801 | Infectious Disease | Coronavirus Disease 2019 (COVID-19) | Phase I | Planned | Sareum Holdings Plc |
| Clinical Study of SDC-1802 | GDCT0334450 | SDC-1802 | Oncology | Anaplastic Large Cell Lymphoma (ALCL); Colon Cancer; Colorectal Cancer; Kidney Cancer (Renal Cell Cancer); Melanoma; Pancreatic Cancer; Solid Tumor; T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia); Unspecified B-Cell Lymphomas | Phase I | Planned | Sareum Holdings Plc |
| A Phase Ib/II Trial of SRA737 in Combination with Gemcitabine plus Cisplatin or Gemcitabine Alone in Subjects with Advanced Cancer | GDCT0255174 | SRA-737 | Oncology | Advanced Malignancy; Anal Cancer; Carcinomas; Cervical Cancer; Dedifferentiated Liposarcoma; Fallopian Tube Cancer; Leiomyosarcoma; Lung Cancer; Malignant Fibrous Histiocytoma; Ovarian Cancer; Peritoneal Cancer; Pleomorphic Liposarcoma; Sarcomas; Small-Cell Lung Cancer; Soft Tissue Sarcoma; Solid Tumor; Vaginal Cancer; Vulvar Cancer | Phase I/II | Completed | Sierra Oncology Inc |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer